索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]杜艳丽,蒋金法.长链非编码RNA在心血管疾病中的研究进展[J].国际心血管病杂志,2017,04:199-202.
点击复制

长链非编码RNA在心血管疾病中的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年04期
页码:
199-202
栏目:
综述
出版日期:
2017-07-25

文章信息/Info

Title:
-
作者:
杜艳丽; 蒋金法
200065 上海,同济大学附属同济医院
Author(s):
-
关键词:
长链非编码RNA; 动脉硬化; 心肌梗死; 心室重构; 心力衰竭
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.04.003
文献标识码:
-
摘要:
长链非编码RNA(lncRNAs)是指长度>200个核苷酸的转录物,它可以干扰基因表达及各个阶段的信号转导。该文主要介绍小鼠和人类lncRNAs的表达情况,以及lncRNAs在心脏发育和心血管疾病中的作用。
Abstract:
-

参考文献/References

[1] Xie C, Yuan J, Li H, et al. NONCODEv4: exploring the world of long non-coding RNA genes[J]. Nucleic Acids Res, 2014, 42(Database issue):D98-D103.
[2] Uchida S, Dimmeler S. Long noncoding RNAs in cardiovascular diseases[J]. Circ Res, 2015, 116(4):737-750.
[3] Kurian L, Aguirre A, Sancho-Martinez I, et al. Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development[J]. Circulation, 2015, 131(14):1278-1290.
[4] Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse[J]. Dev Cell, 2013, 24(2):206-214.
[5] Klattenhoff CA, Scheuermann JC, Surface LE, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment[J]. Cell, 2013, 152(3):570-583.
[6] Ounzain S, Pezzuto I, Micheletti R, et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease[J]. J Mol Cell Cardiol, 2014, 76:55-70.
[7] Li K, Blum Y, Verma A, et al. A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo.[J]. Blood, 2010, 115(1):133-139.
[8] Hou J, Zhou C, Long H, et al. Long noncoding RNAs: Novel molecules in cardiovascular biology, disease and regeneration[J]. Exp Mol Pathol, 2016, 100(3):493-501.
[9] Michalik KM, You X, Manavski Y, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth[J]. Circ Res, 2014, 114(9):1389-1397.
[10] Bell RD, Long X, Lin M, et al. Identification and initial functional characterization of a human vascular cell—enriched long noncoding RNA[J]. Arterioscler Thromb Vasc Biol, 2014, 34(6):1249-1259.
[11] Wu G, Cai J, Han Y, et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity[J]. Circulation, 2014, 130(17):1452-1465.
[12] Zangrando J, Zhang L, Vausort M, et al. Identification of candidate long non-coding RNAs in response to myocardial infarction[J]. BMC Genomics, 2014, 15:460.
[13] Kumarswamy R, Bauters C, Volkmann I, et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure[J]. Circ Res, 2014, 114(10):1569-1575.
[14] Yan Y, Zhang B, Liu N, et al. Circulating long noncoding RNA UCA1 as a novel biomarker of acute myocardial infarction[J]. Biomed Res Int, 2016, 2016:8079372.
[15] Wang k, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489[J]. Circ Res, 2014, 114(9):1377-1388.
[16] Han P, Li W, Lin CH, et al. A long noncoding RNA protects the heart from pathological hypertrophy[J]. Nature, 2014, 514(7520):102-106.
[17] Peters T, Hermans-Beijnsberger S, Beqqali A, et al. Long non-coding RNA malat-1 is dispensable during pressure overload-induced cardiac remodeling and failure in mice[J]. PLoS One, 2016, 11(2):e0150236.
[18] Zhang L, Hamad EA, Vausort M, et al. Identification of candidate long noncoding RNAs associated with left ventricular hypertrophy[J]. Clin Transl Sci, 2015, 8(2):100-106.
[19] Greco S, Zaccagnini G, Perfetti A, et al. Long noncoding RNA dysregulation in ischemic heart failure[J]. J Transl Med, 2016, 14(1):183.
[20] Gao W, Zhu M, Wang H, et al. Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population[J]. Mutat Res, 2015, 772:15-22.

备注/Memo

备注/Memo:
基金项目:上海市科委引导项目(14411971600)
通信作者:蒋金法,Email:jiangjinfa83@163.com
更新日期/Last Update: 2017-07-25